Introduction
============

Short chain fatty acids (SCFA) are generated in the rumen by microbial fermentation of dietary carbohydrates. Absorption of SCFA across the epithelium contributes 70--80% of the total energy requirement of the ruminants. Acetate, propionate and butyrate are the main SCFA in rumen fluid ([@B2]; [@B36]) which induces morpho-functional alteration in ruminal papillae ([@B10],[@B11]; [@B21]; [@B36]). Conversely, an increase of SCFA absorption has been linked to the surface area enlargement of ruminal papillae in ruminants fed high concentrate diets ([@B8]; [@B10],[@B11]). The latter could be ascribed to an increased abundance of gene transcripts related to epithelial proliferation ([@B39]). Butyrate is a four-carbon SCFA normally produced in the smallest ratio of 5--15% in rumen ([@B2]; [@B36]). It is preferred metabolic fuels for rumen epithelium and concerned with mucosal health maintenance ([@B16]; [@B23]). The inner wall of the rumen is covered with rumen papillae which increases the surface area for absorption of nutrients ([@B30]). The morphological and functional changes in ruminal papillae can be largely ascribed to butyrate ([@B21]; [@B44]). Previous studies indicated that sodium butyrate modulates epithelial growth through cell proliferation, differentiation and apoptosis in the small intestine of piglets and stomach of calves and goats ([@B19]; [@B15]; [@B30]). Butyrate improved papillae size and thereby increased surface area in the dorsal sac of the rumen in bulls ([@B20]). Increasing luminal butyrate concentration either by enhancing its endogenous production through dietary manipulation ([@B14]) or by exogenous administration ([@B42]; [@B44]) has been shown to enhance ruminal epithelial proliferation. The proliferative effects of butyrate differ not only with the age and physiological status of the animals but also with the dose, route and rate of butyrate administration. In young calves and starved adult sheep butyrate induces epithelial proliferation at high doses \> 2.5 g/kg of BW/day ([@B42]; [@B33]) and in fed cattle at low doses \< 0.5 g/kg of BW/day ([@B44]). Furthermore, the rapid infusion of butyrate induced proliferation whereas the slow infusion method did not ([@B42]; [@B33]). In addition to cell proliferation, apoptosis is a vital process involved in the maintenance of the cell homeostasis and modulates the organ growth. Besides rapid proliferation, butyrate also stimulates the apoptosis in order to maintain the normal cell homeostasis ([@B33]). Oral administration of butyrate reduced apoptosis in ruminal epithelium of calves. In colonic epithelial cell culture, the butyrate deprived medium reduced cell number in each phase of cell cycle, with the maximum reduction in G1 phase caused by apoptosis ([@B29]). *In vivo* butyrate administration exerts selective effects on cells depending on their phenotypes. Butyrate increased proliferation of normal intestinal cells in piglets ([@B18]) whereas inhibited proliferation and increased apoptosis in artificially induced-tumor cells (aberrant crypt foci, ACF) in rat intestine ([@B5]). It seems that butyrate stimulates apoptosis only in unwanted or defective cells produced during rapid proliferation.

Though the considerable studies have been carried out to evaluate the influence of butyrate on ruminal epithelial growth but the underlined molecular mechanism particularly in reference with cell cycle and apoptosis has not been fully discovered yet. In continuation with our previous study, in which we showed that butyrate induced ruminal epithelial growth is associated with cyclin D1 upregulation, the present study was intended to explore further the influence of butyrate on expression of genes involved in cell cycle and apoptosis.

Materials and Methods {#s1}
=====================

The experimental plan and procedures were approved by Animal Care and Use Committee for Livestock at Nanjing Agricultural University following the requirements of the regulations for the administration of affairs concerning experimental animals under the "The State Science and Technology Commission of China, 1988" act.

Experimental Design, Goat Management, and Infusion Method
---------------------------------------------------------

Twenty four rumen-fistulated goats (Boer × Yangtze River Delta White) of approximately 4 months of age; 18.29 ± 0.64 kg of body weight (BW) at the start of the experiment were used in this study. The goats were housed in individual cemented floor pens (1.2 m × 1.0 m) and were randomly divided into two groups, i.e., A and B (*n* = 12 each). Animals in group B were given intraruminal infusion of sodium butyrate (Merck, Hohenbrunn, Germany) at the dose rate of 0.3 g/kg of BW added in 50 ml of 0.1 mol/l potassium phosphate buffer. Whereas animals in group A received the same amount of buffer without butyrate. The butyrate infusion was performed 1 h before morning feeding within 10--15 s. Animals were fed concentrate (200 g) two times daily in 2 equal meals at 8:00 am and 5:00 pm and provided with free access to hay and water. **Table [1](#T1){ref-type="table"}** depicts all of the ingredients in the feed and their chemical compositions. Body weight of goats was recorded weekly. The duration of the experiment was 28 days.

###### 

Chemical composition of diets fed to goats.

  Chemical composition    Concentrate^†^   Hay
  ----------------------- ---------------- ------
  DM (%)                  87.7             89.8
  CP (% of DM)            20.8             7.3
  Crude fat (% of DM)     3.6              2.0
  Crude fiber (% of DM)   6.6              28.2
  Crude ash (% of DM)     7.7              6.4
  ME (MJ/kg of DM)        10.8             6.9

†

The concentrate was composed of ground corn, soybean meal, cottonseed bran, wheat bran, fish meal, calcium phosphate, limestone, trace mineral salt, and vitamin premix (vitamins A, D, and E). DM, dry matter; CP, crude protein; ME, metabolizable energy; MJ, Megajoule.

Sampling and chemical analysis of the feed was performed on days 7 and 28. On day 14 of infusion trial the ruminal fluid samples were collected in equal portion from atrium ruminis, ventral rumen and caudal dorsal and caudal ventral regions by suction through inserting a pipe and combined to form one sample at 0, 1, 2.5, 3.5, 5, and 7 h post-infusion. The pH was determined by digital pH meter and then the samples were immediately strained through 4 layers of gauze. Afterwards, 1 ml of 5% HgCl~2~ solution was added to 20 ml of rumen fluid and preserved at -20°C for SCFA analysis. Goats were slaughtered on day 28 (4 goats from each group) at three different time points, i.e., 5, 7, and 9 h after last infusion. After slaughter, the abdomens were immediately opened, and the stomachs were exteriorized. After emptying and washing with PBS (pH 7.4), ruminal tissues (approximately 2 cm^2^) from the atrium ruminis, ventral rumen sac and ventral blind sac were taken for morphological analyses of the papillae. These tissues were fixed in 4% paraformaldehyde solution. Epithelium for RNA extraction was taken from ventral blind sac (∼10 g). After cleansing with ice-cold PBS, the epithelium was detached from muscle layer by hand, shifted into liquid nitrogen and then stored at -80°C until analyzed for PCR.

Determination of Ruminal SCFA Concentration
-------------------------------------------

The SCFA concentrations in the ruminal fluids were detected using a HP6890N chromatograph (Agilent Technologies, Wilmington, DE, United States) according to a standard method ([@B48]). The carrier gas was nitrogen (99.99% purity) and was applied at a steady flow rate of 2.8 ml/min with a split ratio of 1:30. The capillary column temperature was fixed at 140°C for 4 min and then increased at 25°C/min to 240°C. Regarding the injection port and the flame-ionization detector (FID), the temperatures were set to 180 and 250°C, respectively. Crotonic acid (CH~3~CH) was used as the internal standard.

Morphometric and Histomorphometric Analyses
-------------------------------------------

One centimeter square piece of paraformaldehyde fixed epithelium, taken from each of the anterior, ventral and ventral blind sac of the rumen was used for morphological analyses of the papillae. Papilla was held gently with forceps and the caliper was slowly opened wide, from base to the tip of papilla to measure the length, and from one side to the other at the mid of papillae to measure the width. The papillae were cut from these epithelial sections and counted (density, number/cm^2^). For every goat in groups B and A, 15 papillae were measured from each of the samples of the atrium ruminis, ventral rumen sac and ventral blind sac. The surface areas of the rumen mucosa (mm^2^/cm^2^) were determined as the length × width × density × 2.

For the histomorphological evaluations, the formalin fixed tissue samples from the atrium ruminis were taken, dehydrated, cleared and embedded in paraffin. Sections of 4-μm thickness were cut and stained by the standard hematoxylin and eosin (H&E) procedure. For each tissue, 25 to 30 papillae were embedded for paraffin-sectioning and microscopic observation. From these, the 4 paraffin sections with the best orientation of papillae in the median sagittal plane were used to evaluate the morphological characteristics of the ruminal papillae by using Image-Pro Plus 6.0 (Media Cybernetics Inc., Bethesda, MD, United States).

For each papillae three visual fields were used for counting cell density from three cell layers of the epithelium, i.e., SS+ SG = the stratum germinativum (SGv) and stratum basale (SB), to reveal the following parameters:

1.  The epithelial cell density of the SGvs in numbers of cells per mm^2^ (n/mm^2^).

2.  The epithelial cells in SB are in single row and there counting unit is numbers of cells per mm (n/mm).

Total RNA Extraction, cDNA Synthesis and Quantitative Real-Time PCR
-------------------------------------------------------------------

The guanidinium thiocyanate-phenol-chloroform extraction method reported by [@B4] was used for the total RNA extraction from the homogenized ruminal tissue. The RNA concentration and integrity were evaluated based on extinction measurements at 260 and 280 nm made with a Biophotometer (Eppendorf, Hamburg, Germany). The absorption ratio (260:280) was between 1.8 and 2.0 for all of the RNA samples, which indicated high RNA purity in every sample. Aliquots of RNA samples were subjected to electrophoresis through a 1.4% agarose-formaldehyde gel to verify integrity. The RNA concentrations in the samples were then adjusted to1 μg/μl. Random hexamer primers (Invitrogen, Shanghai, China) and Moloney murine leukemia virus (M-MLV) reverse transcriptase (Fermentas, Burlington, ON, Canada) were used for the cDNA synthesis. The target genes of interest and their respective sources and primer sequences are listed in **Table [2](#T2){ref-type="table"}**.

###### 

Primers used in quantitative real-time PCR analysis.

  Gene^†^     Primer sequence 5′ to 3′^‡^   Accession number^§^   Size(bp)^¶^
  ----------- ----------------------------- --------------------- -------------
  CCND1       GGTCCTGGTGAACAAACTC           EU525165.1            114
              TTGCGGATGATCTGCTT                                   
  CDK4        TGAGCATCCCAGTGTTGT            NM-001127269.1        122
              CCTTGTCCAGATACTTCCT                                 
  CDK6        AGAGTGATTGCAGCTTTATGTCCA      GAAI01006376.1        158
              TGCCCAGGTTGCTCACTTC                                 
  CCNE1       GGGACAAGCACCTTATGCAAC         NM-001192776.1        153
              GTGTTGCCATATACCGATCAAAGA                            
  CDK2        CTGCACCGAGACCTTAAACCTCA       BT020790.1            140
              GCTCGGTACCACAGAGTCACCA                              
  CCNA        TGGACCTTCACCAGACCTACCT        X68321.1              105
              GTGGGTTGAGGAGAGAAACACC                              
  CCNB1       AGCGGATCCAAACCTTTGTAGTG       NM-001045872.1        137
              CAATGAGGATGGCTCTCATGTTTC                            
  CDK1        CCAATAATGAAGTGTGGCCAGAAG      NM-174016.2           164
              AGAAATTCGTTTGGCAGGATCATAG                           
  p21         AGGGCACGTCTCAGGAGGA           NM_001098958. 1       164
              CAGTCTGCGTTTGGAGTGGTAG                              
  Bax         TCTGACGGCAACTTCAACTG          NM-173894.1           205
              TGGGTGTCCCAAAGTAGGAG                                
  Caspase 3   AGCCATGGTGAAGAAGGAATCA        NM-001077840.1        156
              ACCACAGTCCAGTTCTGTGCCT                              
  Caspase 9   TCCTTTGTTCATCTCCTGCTTG        XM-004013798.1        115
              TTTTCCTTGGCTTGGCTTTG                                
  Bcl-2       GATGACCGAGTATCTGAACCG         NM-001166486.1        120
              GACAGCCAGGAGAAATCAAACA                              
  GAPDH       TTGTCTCCTGCGACTTCA            HM043737.1            135
              CCACCACCCTGTTACTGTT                                 

†

CCND1, cyclin D1; CDK4, cyclin-dependent kinase 4; CDK6, cyclin-dependent kinase 6; CCNE1, Cyclin E1; CDK2, cyclin-dependent kinase 2; CCNA, cyclin A; CCNB1, cyclin B1; CDK1, cyclin-dependent kinase 1; p21, cyclin-dependent kinase inhibitor; Bax, Bcl-2-associatedX protein; Bcl-2, B-cell lymphoma 2; GAPDH mRNA, Glyceraldehyde 3-phosphate dehydrogenase ribosomal RNA.

‡

The first primer listed for each gene is the forward primer and the second primer is reverse primer.

§

Accession number.

¶

The base pair of primers.

The relative gene expression was determined via real-time polymerase chain reaction (PCR) by using the MyiQ2 two-color real-time PCR detection system (Bio-Rad Laboratories, Inc., Hercules, CA, United States). Real-time PCR was performed in a total volume of 20 μl containing 1× iQSYBR Green Supermix (Bio-Rad Laboratories Inc., Hercules, CA, United States), a mixture of the forward and reverses primers (500 nM each), cDNA template (1 ng), and a known amount of sterile water for volume adjustment. An initial cycle of 30 s at 95°C was used to denature the cDNA. Forty PCR cycles involving denaturation at 95°C for 10 s and primer annealing and extension at 55°C for 30 s were then performed. A standard dilution series was used to calculate the amplification efficiencies of all of the primers before performing the PCRs for the experimental samples. The efficiencies of all the primers used were between 97 and 101%. Gene expression was normalized to GAPDH. All samples were run in triplicate. These experiments were repeated twice with 80--90% similarity. Melt curve analyses were performed after all of the PCR analyses. The data were analyzed via PCR array data analyses based on the Δ*C*t method with normalization of the raw data to GAPDH; i.e., ΔCt = *C*t~target~ -*C*t~GAPDH~, where *C*t = the cycle threshold. The relative gene expression values were calculated using the formula 2^-ΔΔ^*^C^*^t^, as explained by ([@B28]). All samples were analyzed in triplicate.

Statistical Analysis
--------------------

Data are expressed as means ± SE. Differences with a *P*-value of \<0.05 were considered significant. An independent sample *t*-test (two-tailed test) was used to compare the data between two groups. All statistical analyses were performed by using SPSS software (version 13.0.1 for Windows; SPSS, Chicago, IL, United States).

Results
=======

Ruminal Short Chain Fatty Acid Concentration
--------------------------------------------

**Figure [1](#F1){ref-type="fig"}** shows the effect of butyrate infusion on ruminal fermentation pattern of goats. At 0 h the individual and total SCFA concentrations did not differ between the groups, however, at 1 h after butyrate infusion, the molar concentration (mmol/l) of butyrate (17.96) in B increased by about 99.78% (*P* \< 0.01) compared to A (8.99). Whereas the molar concentrations (mmol/l) of acetate (48.93 in B vs. 54.50 in A) and propionate (13.54 in B vs. 17.41 in A) were decreased (*P* \< 0.05) in B compared to A. The concentrations of both acetate and propionate in group B returned to the base-line levels by 2.5 h whereas the butyrate concentration remained significantly elevated up to 2.5 h and then returned to its base-line value by 3.5 h.

![Effect of ruminal butyrate infusion on the molar concentration of total short chain fatty acids **(I)**, acetate **(II)**, propionate **(III)**, and butyrate **(IV)** at 6 time points on day 14th of butyrate infusion. The goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 12) or 0 (A = control group, *n* = 12) g/kg of BW per day for 28 days in the experimental duration. Values (means ± SE) differ if they do not share a common letter: ^a,b^*P* \< 0.05.](fphys-09-00496-g001){#F1}

Morphometric and Histometric Analysis of Rumen Papillae
-------------------------------------------------------

Butyrate infusion significantly increased (*P* \< 0.05) the papillae length, width and density in the atrium ruminis (AR), ventral rumen (VR), and ventral blind sac (VBS) compared to group A (**Table [3](#T3){ref-type="table"}** and **Figure [2](#F2){ref-type="fig"}**). The increases in papillae length, width and density led to an increase (*P* \< 0.05) in the surface area of all the tested regions in group B compared to group A. Histometric analysis of rumen papillae revealed that the cell density in the stratum germinativum (SGv) and stratum basale (SB) increased (*P* \< 0.05) in group B compared with group A (**Table [4](#T4){ref-type="table"}** and **Figure [3](#F3){ref-type="fig"}**).

###### 

Effect of butyrate on morphometric parameters of rumen papillae of goat^†^.

  Parameters             5 h             7 h            9 h                                                                           
  ---------------------- --------------- -------------- ------- --------------- -------------- ------- --------------- -------------- -------
  *Atrium ruminis*                                                                                                                    
  Length, mm             5.48 ± 0.21     4.50 ± 0.14    0.011   5.21 ± 0.15     4.11 ± 0.11    0.001   5.61 ± 0.13     4.72 ± 0.19    0.011
  Width, mm              1.91 ± 0.13     1.41 ± 0.10    0.026   1.94 ± 0.11     1.43 ± 0.10    0.017   2.21 ± 0.14     1.62 ± 0.11    0.016
  Density, n/cm^2^       89.25 ± 4.7     71.25 ± 4      0.029   87.50 ± 3.2     75.25 ± 2.8    0.029   88.75 ± 4.3     67.75 ± 3.1    0.010
  Surface, mm^2^/cm^2^   1867.33 ± 136   922.24 ± 131   0.002   1785.60 ± 183   889.83 ± 86    0.010   2199.16 ± 129   1028.78 ± 45   0.001
  *Ventral rumen sac*                                                                                                                 
  Length, mm             4.31 ± 0.13     3.62 ± 0.15    0.015   4.31 ± 0.12     3.77 ± 0.14    0.028   4.54 ± 0.18     3.70 ± 0.15    0.013
  Width, mm              1.81 ± 0.07     1.40 ± 0.07    0.008   1.81 ± 0.06     1.60 ± 0.04    0.039   1.93 ± 0.13     1.54 ± 0.10    0.057
  Density, n/cm^2^       93.00 ± 4.4     78.50 ± 3.7    0.047   91.75 ± 3.7     74.0 ± 2.9     0.010   89.75 ± 3.1     73.0 ± 4.4     0.024
  Surface, mm^2^/cm^2^   1449.13 ± 49    803.04 ± 76    0.001   1438.27 ± 110   895.23 ± 57    0.005   1580.03 ± 119   824.34 ± 35    0.001
  *Ventral blind sac*                                                                                                                 
  Length, mm             3.46 ± 0.12     2.70 ± 0.13    0.006   3.22 ± 0.12     2.58 ± 0.15    0.019   3.42 ± 0.14     2.75 ± 0.15    0.020
  Width, mm              1.75 ± 0.08     1.30 ± 0.07    0.010   1.70 ± 0.06     1.48 ± 0.04    0.032   1.74 ± 0.15     1.30 ± 0.08    0.054
  Density, n/cm^2^       89.75 ± 2.6     77.75 ± 3.8    0.041   90.75 ± 5       74.75 ± 3.90   0.046   85.25 ± 4.2     71.25 ± 4.2    0.059
  Surface, mm^2^/cm^2^   1091.93 ± 83    553.21 ± 62    0.002   991.37 ± 52     574.64 ± 41    0.001   1009.02 ± 80    505.92 ± 35    0.001

†

Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group) or 0 (A = control group) g/kg of BW per day for 28 days. Values are mean ± SE.

![Effect of ruminal butyrate infusion on papillae growth. Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 12) or 0 (A = control group, *n* = 12) g/kg of BW per day for 28 days.](fphys-09-00496-g002){#F2}

###### 

Effect of ruminal butyrate infusion on cell density of rumen epithelial strata in goats^†^.

  Parameters        5 h             7 h             9 h                                                                             
  ----------------- --------------- --------------- ------- --------------- --------------- ------- --------------- --------------- -------
  SS+ SG, n/mm^2^   9148.18 ± 291   7936.03 ± 186   0.010   9096.93 ± 264   7797.93 ± 125   0.010   8047.62 ± 258   6883.95 ± 197   0.012
  SB, n/mm          292.04 ± 13.2   250.83 ± 4.9    0.027   293.87 ± 15.0   246.58 ± 4.8    0.042   283.75 ± 12.4   242.52 ± 4.1    0.039

†

Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, n = 4) or 0 (A = control group, n = 4) g/kg of BW per day for 28 days. SS, stratum spinosum; SG, stratum granulosum; SB, stratum basale. Values are mean ± SE.

![Effect of ruminal butyrate infusion on rumen papillae histology. Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 12) or 0 (A = control group, *n* = 12) g/kg of BW per day for 28 days. Histomicrographs showing epithelial strata at maximum (a) and minimum (b) depths in epithelium of goats. Morphological characteristics of the ruminal papillae observed by using Image-Pro Plus 6.0 (Media Cybernetics Inc., Bethesda, MD, United States).](fphys-09-00496-g003){#F3}

Gene Expression Analyses
------------------------

The mRNA expression levels of cyclin D1, CDK4, CDK6, CDK2, and p21 were significantly increased (*P* \< 0.05) in group B compared to A at 5 h after butyrate infusion (**Figure [4I](#F4){ref-type="fig"}**). Whereas the butyrate infusion increased (*P* \< 0.05) the mRNA expression levels of cyclin E1 at 7 h and that of cyclin A and CDK1at 9 h post-infusion compared to A (**Figures [5I](#F5){ref-type="fig"}, [6I](#F6){ref-type="fig"}**). The assessment of genes showed that the butyrate infusion caused significant increase (*P* \< 0.05) in mRNA expression levels of caspase 3, caspase 9 and Bax at 5 h post-infusion compared to control (**Figure [4II](#F4){ref-type="fig"}**). However, the expression levels of apoptotic genes at 7 and 9 h post-infusion were remained unchanged (*P* \> 0.05) between the groups (**Figures [5II](#F5){ref-type="fig"}, [6II](#F6){ref-type="fig"}**). Furthermore, the increased mRNA expression levels of cyclin D1, cyclin E1, CDK2, 4, and 6, and P21, caspase 3, caspase 9 and Bax were positively correlated with the ruminal butyrate concentration in B and the differences were significant (*P* ≤ 0.05, **Table [5](#T5){ref-type="table"}**).

![Effect of ruminal butyrate infusion on mRNA expression of **(I)** proliferation and cell cycle inhibition and **(II)** apoptosis related genes in the rumen epithelium of goats. Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 4) or 0 (A = control group, *n* = 4) g/kg of BW per day for 28 days and slaughtered on day 28 at 5 h after infusion. The levels of gene expression were calculated with real-time PCR in comparison with GAPDH mRNA. Values are mean ± SE. Asterisks exhibit the differences between groups with ^∗^*P* \< 0.05.](fphys-09-00496-g004){#F4}

![Effect of ruminal butyrate infusion on mRNA expression of **(I)** proliferation and cell cycle inhibition and **(II)** apoptosis related genes in the rumen epithelium of goats. Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 4) or 0 (A = control group, *n* = 4) g/kg of BW per day for 28 days and slaughtered on day 28 at 7 h after infusion. The levels of gene expression were calculated with real-time PCR in comparison with GAPDH mRNA. Values are mean ± SE. Asterisks exhibit the differences between groups with ^∗^*P* \< 0.05.](fphys-09-00496-g005){#F5}

![Effect of ruminal butyrate infusion on mRNA expression of **(I)** proliferation and cell cycle inhibition and **(II)** apoptosis related genes in the rumen epithelium of goats. Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group, *n* = 4) or 0 (A = control group, *n* = 4) g/kg of BW per day for 28 days and slaughtered on day 28 at 9 h after infusion. The levels of gene expression were calculated with real-time PCR in comparison with GAPDH mRNA. Values are mean ± SE. Asterisks exhibit the differences between groups with ^∗^*P* \< 0.05.](fphys-09-00496-g006){#F6}

###### 

Correlation between ruminal butyrate and mRNA concentration level of genes.

  Item                   *r*       *P*-value
  ---------------------- --------- -----------
  Butyrate × Cyclin A    0.146     0.730
  Butyrate × Cyclin B1   --0.048   0.910
  Butyrate × Cyclin D1   0.773     0.025
  Butyrate × Cyclin E1   0.713     0.047
  Butyrate × CDK1        0.075     0.859
  Butyrate × CDK2        0.864     0.006
  Butyrate × CDK4        0.954     0.000
  Butyrate × CDK6        0.773     0.024
  Butyrate × P21         0.892     0.003
  Butyrate × Caspase 3   0.789     0.020
  Butyrate × Caspase 9   0.927     0.001
  Butyrate × Bax         0.863     0.006
  Butyrate × Bcl-2       --0.028   0.947

Goats were infused by 0.1 M potassium phosphate buffer (50 ml) with sodium butyrate at 0.3 (B = butyrate group) or 0 (A = control group) g/kg of BW per day for 28 days. mRNA concentration was analyzed for correlation with ruminal butyrate concentration. (r) = measure of the strength of the association between butyrate concentration and mRNA of genes.

Discussion
==========

Fermentation Pattern and Morphology of Rumen
--------------------------------------------

Butyrate concentration in rumen fluid of B group increased from 1 to 2.5 h post-infusion compared to A group and declined subsequently. Conversely the molar concentration of acetate and propionate significantly decreased at 1 h post-infusion. The changes in the concentration of three major ruminal SCFAs in response to intraruminal infusion of butyrate are consistent with previous study ([@B30]). The reduction of acetate and propionate might be due to inhibitory impact of butyrate on their production by ruminal microbes ([@B27]) or butyrate could promote the absorption of acetate and propionate by the ruminal epithelium ([@B30]). In the present study the ruminal infusion of butyrate increased dimensions and density of papillae in atrium ruminis, ventral sac and ventral blind sac of rumen. Furthermore, the histometric analysis showed that the number of cell layers in SGv and density of cells in SB increased in butyrate infused goats compared to control. This could be largely attributed to increased intraruminal butyrate concentration as previously reported by ([@B33]; [@B44]; [@B30]).

Genes Expression Related to Proliferation and Apoptosis
-------------------------------------------------------

In the present study, the butyrate infusion showed time-dependent effects on genes related to cell cycle and apoptosis in ruminal epithelium. The mRNA expressions level of cell cycle genes involved in early to mid G1 phase, i.e., cyclin D1, CDK2, CDK4, and CDK6 increased at 5 h and those involved in late G1 phase, i.e., cyclin E1 at 7 h after butyrate infusion. Based on histo-morphometric studies, many researchers have demonstrated that butyrate improves rumen epithelial growth through increased cell proliferation ([@B42]; [@B33]; [@B45]). The cell cycle of a mammalian cell including ruminal epithelium is a complex process consisting of four phases including G1, G2, S, and M ([@B12]; [@B31]). In general, the rumen epithelial cells complete the cell cycle in a period of 24 h, however, the duration may increase or decrease depending upon shortening or elongation of various cell cycle phases under the influence of diet or dietary-produced SCFA ([@B12]). The cell cycle phases are strictly regulated by cyclins and cyclin-dependent kinases (CDK) proteins ([@B32]; [@B17]). Cyclin D1 forms a complex with either CDK4/6 that promotes the cells from early to mid G1 phase ([@B31]). The upregulation of cyclin D1 and CDK 4/6 at 5 h after butyrate infusion suggest that butyrate enhanced the transition of cells through G~0~/mid-G1 phase. The cyclin E1 mRNA synthesis is initiated during the G1 phase and its expression reaches at its peak in late G1 ([@B40]; [@B6]). In the present study, the increased cyclin E1 mRNA expression level in ruminal epithelial tissue collected at 7 h post-infusion suggest that the cell population was in G1/S transition phase. If we presume that at the time of butyrate infusion (0 h) the ruminal epithelial cells were in G~0~-phase, the cells took 4--5 h to enter mid-G1 phase and another 2--3 h to enter the mid/late G1 phase and the total duration of G1-phase would be 6--7 h. In sheep fed roughage-based diet, the maximum duration of G1 phase in rumen epithelial cells was 8.2 h which reduced to 6.5 h when the sheep were transitioned from roughage to concentrate based-diet ([@B12]). Previous studies have shown that butyrate induces ruminal epithelial growth in goats by shortening G1 phase through cyclin D1 upregulation ([@B30]). Moreover, the cyclin D1 expression was influenced by sampling time. According to our previous report, ruminal tissue samples collected at 3 h post-infusion of butyrate already showed significant increase in cyclin D1 mRNA expression level compared to control whereas at 7 h post-infusion did not ([@B30]). In the present study, we also observed that cyclin D1 expression was remained elevated at the ruminal tissue samples collected at 5 h post-infusion but not at 7 h post-infusion (**Figure [4](#F4){ref-type="fig"}**). On the other hand, we found significantly increased CDK4 expression (**Figure [4](#F4){ref-type="fig"}**) but they not observe any change in CDK4 ([@B30]). The reason of this contradiction is not clear. To our best knowledge, the influence of *in vivo* butyrate on cyclins A, B and E1, and CDK 1 and 2 and their possible role in ruminal epithelial growth has not been previously reported. However, high concentrate diet-induced ruminal epithelial proliferation was associated with modulation of cell cycle genes including cyclins D1, E1, A and B, and CDK 2/4 and 6 ([@B13]). The activity of cyclin E requires CDK2 with which it forms cyclin E1/CDK2 complex that derives the cell cycle through late G1/S phase ([@B46], [@B47]). However, in the present study, we did not observe any change in CDK2 mRNA expression. This suggests that there could be an alternate mechanism for binding with cyclin E1 to drive the late G1 events of cell cycle. The loss of CDK2 in mice did not affect G1/S transition and cell cycle progression and it was suggested that either cyclin E1 performed independent of CDK2 ([@B3]; [@B38]) or possibly formed cyclin E/CDK1 complex ([@B1]). Recently, it has been shown that cyclin E1 activates CDK3 and forms cyclin E/CDK3 complex to promote G1/S transition ([@B43]).

Once the cells enter the S-phase the cyclin E1 expression is subsided and the synthesis of cyclin A mRNA is initiated and its expression becomes maximal with the progression of S-phase ([@B40]; [@B6]). In the present study, the cyclin A mRNA expression increased in sample collected at 9 h post-infusion which suggests that the cell population entered the S-phase. The activity of cyclin A requires either CDK1 or 2 to form the complex cyclin A/CDK1/2 which regulates the transition of cells through S-phase. In the present study, the CDK1 mRNA expression concurrently increased with cyclin A mRNA expression. Finally cyclin B is required prior to mitosis (G2/M-phase) ([@B40]; [@B6]) which binds with CDK1 to accomplish cell division ([@B41]). In the present study, no significant changes in cyclin B1 mRNA expression were observed in ruminal epithelial tissue. This can be explained by the fact that cell populations in the tissues collected at specific time points in the present study did not arrive at G2/M-phase of cell cycle. However, the tissue samples collected at 9 h showed that butyrate infusion caused slight increase in cyclin B1 expression which indicates the transition of cells through late-S/G2-M phase since the genes required in next phase of cycle initiate to express in late stage of previous phase ([@B40]; [@B6]). The rise in cyclin B1 expression could be expected if the fourth ruminal tissue sample were collected at certain time-point after 9 h post-infusion. The present data demonstrate that the proliferative effects of butyrate depend upon the specific stage of dividing cells. Thus, while performing *in vivo* experiments the location and tissue sampling time is very important because the tissue sample collected from a particular site at one specific time would represent the cell population in a particular phase of cell cycle with expression of associated genes ([@B25]; [@B48]).

In the present study, the butyrate infusion increased p21 mRNA expression level in ruminal tissue collected at 5 h post-infusion. The p21 has anti-proliferative effects which binds with CDKs and prevent cell cycle progression and arrest cell cycle at any phase through G0/G2 phases ([@B37]; [@B35]). It has been shown that the increased proliferation rate in rumen epithelium leads to rise in apoptosis in order to maintain the normal cell homeostasis ([@B33]). Consistent with our findings, ([@B7]) have shown that *in vivo* butyrate administration upregulated p21 expression in colonocytes of rats. In addition, butyrate-induced p21 upregulation increased apoptosis in artificially induced-tumor cells (aberrant crypt foci, ACF) in rats fed fish oil but no apoptotic effects were observed in ACF in rats fed corn oil. This suggests that apoptotic effects of butyrate depend upon the associated factors and physiological status of the cell even after p21 upregulation. Many studies have shown such selective effects of *in vivo* butyrate which depend upon physiological status and cellular phenotypes. Cecal infusion of butyrate increased proliferation of normal intestinal cells in piglets ([@B18]) whereas butyrate inhibited proliferation and increased apoptosis in artificially induced-ACF in rat intestine ([@B5]). The results of present study demonstrate that butyrate induced apoptosis in ruminal epithelial cells during rapid proliferation, since the overall ratio of proliferation was higher than the apoptosis which was reflected in epithelial growth (**Figure [7](#F7){ref-type="fig"}**).

![Schematic diagram showing influence of ruminal Sodium Butyrate (SB) infusion on expression of genes related to proliferation and apoptosis in rumen epithelium of goat. SB increased proliferation through upregulation of cell cycle related genes involved in early G1 (cyclin D1, CDK2, CDK4, and CDK6), mid G1 (cyclin E1) and S phase (cyclin A and CDK1). Simultaneously, SB also increased the mRNA expression level of p21, Bax, Caspases 3 and 9, leading to cell cycle arrest and apoptosis. Since, the rate of proliferation was higher than apoptosis which was reflected in ruminal epithelial growth and papillae enlargement.](fphys-09-00496-g007){#F7}

For normal growth and tissue homeostasis a balance between cell proliferation and apoptosis is important. Depending on the cellular context these two antagonistic processes are linked via shared molecular machinery ([@B9]). In the present study, the butyrate infusion caused upregulation of proapoptotic genes, i.e., Bax, caspase 3 and caspase 9 in ruminal epithelial tissues at 5 h post-infusion, however, the expressions of apoptotic genes at 7 and 9 h were not influenced by the butyrate treatment. This suggests that butyrate induced apoptosis in ruminal epithelial cells by arresting cell cycle at G1. The inhibitory effects of butyrate on G1 phase of cell cycle and the induction of apoptosis have been well established ([@B24]; [@B26]; [@B31]). As mentioned earlier that p21 is also upregulated at the same time point which suggests the involvement of p21 pathway in butyrate-induced apoptosis. Consistent with our findings, previous studies have shown that *in vivo* butyrate administration increased apoptosis through p21-dependent pathway in prostate cancer cell lines implanted in mice ([@B22]). Over expression of caspase 3, caspase 9, and Bax in the present study indicate that butyrate involved p21-dependent intrinsic pathway mediated by Bax and caspase 3. In prostate cancer cells butyrate treatment up-regulated Bax ([@B34]).

Conclusion
==========

The present study demonstrates that butyrate stimulates epithelial growth by modulating both proliferative and apoptotic genes. Butyrate enhanced ruminal epithelial proliferation by shortening various cell cycle phases through associated cyclins/CDKs upregulation. Besides proliferation, butyrate induced apoptosis in rumen epithelium through activation of Bax, caspase 3, and caspase 9. Since the ratio of proliferation was higher than the apoptosis which was reflected in epithelial growth. To our knowledge, we report for the first time the effects of *in vivo* butyrate infusion on cell cycle and apoptotic genes in rumen epithelium of goats. Moreover, the environment of large intestine in mammals generally resembles with the environment of rumen so the results of present study can be extrapolated on mammals including human beings. However, the results of present study may be carefully interpreted as rumen epithelium is a complex tissue consisting of four different types of cell layers and the effects of butyrate vary with cell phenotypes. Nevertheless, this study provides a basis for understanding the molecular mechanism underlying the butyrate action on ruminal epithelial growth.
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